Syphilis: Back With a Vengeance
Injectable penicillin is the go-to treatment for syphilis and the only treatment considered safe for pregnant people with the disease.
Suicide is an Epidemic Most Physicians Cannot Treat
Suicide has reached epidemic proportions in the US − yet medical students still don’t receive adequate training to treat suicidal ...
SAMHSA Makes Permanent Increased Access to OUD Medications
The Biden administration announced that policies put in place during the pandemic will continue permanently.
How False Narratives Affect LQBTQ+ Rights
We expose the rhetorical tricks and strategic deceptions used to skew clinical science against marginalized groups.
A Patient’s Existential Angst
Healthcare, as we see it, is defined through broad statistics. For the patient, healthcare is the unique day to day ...
Hidden Flaw in Observational Studies
One way in which observational studies can be manipulated is by playing with the time horizon of the study data.
Why Nobody Wants to be a PCP
It’s hard to know if any policy is working given that the data on primary care shortage areas has been ...
Let’s Measure Patient Virality
We're spearheading a unique initiative to study the component elements of how patient stories become viral.
A Call to Study MCAT Implicit Bias
We will soon begin the initial cohort of students who will learn how to analyze MCAT exam structure and syntax.
Rule of Law in Medicine has Died
You will often find that the worst violations of human rights will be committed by a party supposedly dedicated to ...
When Hospitals Don’t Help Patients
Even though the government requires nonprofit hospitals to assess the health needs of surrounding areas, many still struggle to get ...
As I Sat in Court Watching the DEA
A patient advocate details her experience watching the DEA claim that patients don't have a right to intervene for their ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more